Danyelza and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Danyelza (naxitamab-gqgk), especially for people who are female, 2-9 old, have been taking the drug for < 1 month also take Sodium Chloride, and have Neuroblastoma.

The phase IV clinical study analyzes which people have Rashes when taking Danyelza. It is created by eHealthMe based on reports of 128 people who have side effects when taking Danyelza from the FDA, and is updated regularly.

What is Danyelza?

Danyelza has active ingredients of naxitamab-gqgk. eHealthMe is studying from 128 Danyelza users. Check the latest studies of Danyelza.

What is Rashes?

Rashes (redness) is found to be associated with 3,714 drugs and 6,214 conditions by eHealthMe. Check the latest studies of Rashes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

128 people reported to have side effects when taking Danyelza.
Among them, 28 people (21.88%) have Rashes.

Among these 28 people:

How long have people been on Danyelza when they have Rashes? *

What is the gender of people who have Rashes when taking Danyelza? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Rashes when taking Danyelza? *

What are other drugs people take besides Danyelza? *

Sodium Chloride: 13 people, 46.43%
Acetaminophen: 9 people, 32.14%
Methylprednisolone: 9 people, 32.14%
Famotidine: 7 people, 25.00%
Ondansetron: 7 people, 25.00%
Oxycodone: 5 people, 17.86%
Leukine: 5 people, 17.86%
Methylprednisolone Sodium Succinate: 5 people, 17.86%
Morphine: 5 people, 17.86%
Ibuprofen: 5 people, 17.86%

What are other side effects people have besides Rashes? *

Hypotension (abnormally low blood pressure): 18 people, 64.29%
Pain: 10 people, 35.71%
Urticaria (rash of round, red welts on the skin that itch intensely): 8 people, 28.57%
Oxygen Saturation Decreased: 8 people, 28.57%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 7 people, 25.00%
Breathing Sounds - Abnormal (Stridor): 5 people, 17.86%
Cough: 5 people, 17.86%
Fever: 5 people, 17.86%
Nausea And Vomiting: 5 people, 17.86%
High Blood Pressure: 5 people, 17.86%

What are the existing conditions these people have? *

Neuroblastoma (a cancer that forms in your nerve tissue): 17 people, 60.71%
Neuroblastoma Recurrent (reoccurrence of a cancer that forms in your nerve tissue): 11 people, 39.29%
Pain: 2 people, 7.14%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 3.57%
Thrombocytopenia (decrease of platelets in blood): 1 person, 3.57%
Hypersensitivity: 1 person, 3.57%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 3.57%
Ganglioneuroblastoma (tumour arising from either the dorsal root ganglion of the spinal cord or the medulla of the adrenal gland): 1 person, 3.57%
Fever: 1 person, 3.57%
Allergic Rhinitis: 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Danyelza and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Danyelza:

Danyelza (128 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Danyelza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,714 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on naxitamab-gqgk (the active ingredients of Danyelza) and Danyelza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.